Details for New Drug Application (NDA): 088791
✉ Email this page to a colleague
NDA 088791 describes VASOCIDIN, which is a drug marketed by Novartis and is included in two NDAs. Additional details are available on the VASOCIDIN profile page.
The generic ingredient in VASOCIDIN is prednisolone sodium phosphate; sulfacetamide sodium. There are eighty-eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the prednisolone sodium phosphate; sulfacetamide sodium profile page.
The generic ingredient in VASOCIDIN is prednisolone sodium phosphate; sulfacetamide sodium. There are eighty-eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the prednisolone sodium phosphate; sulfacetamide sodium profile page.
Summary for 088791
| Tradename: | VASOCIDIN |
| Applicant: | Novartis |
| Ingredient: | prednisolone acetate; sulfacetamide sodium |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | OINTMENT;OPHTHALMIC | Strength | 0.5%;10% | ||||
| Approval Date: | Oct 5, 1984 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
